中荷人寿去年保费规模稳步增长 最近三年综合投资收益率排名却从业内上游滑落至垫底

Core Viewpoint - In 2025, Zhonghe Life Insurance experienced a significant decline in its comprehensive investment return rate, dropping to -2.26%, ranking last among 57 non-listed life insurance companies, after achieving a high of 14.42% in 2024 [1][4]. Group 1: Investment Performance - In 2023, Zhonghe Life's comprehensive investment return rate was 5.83%, significantly above the industry average, ranking ninth [1]. - The company achieved a comprehensive investment return rate of 14.42% in 2024, ranking fifth among non-listed life insurance companies [1]. - In 2025, the investment return rate for the fourth quarter was only 0.78%, with an annual cumulative investment return rate of 3.87%, placing it at the lower end of the industry [4]. Group 2: Premium Income and Growth - In the fourth quarter of 2025, Zhonghe Life reported a single-quarter premium income of 1.95 billion yuan, maintaining a high growth rate of 36.48% from the first half of the year [1]. - The total premium income for the year reached 20.88 billion yuan, representing a year-on-year growth of over 36%, significantly outperforming peers [1]. Group 3: Regulatory and Operational Challenges - In 2025, six branches of Zhonghe Life faced regulatory penalties totaling 760,000 yuan due to issues such as false financial data and fraudulent invoicing [5]. - Consumer complaints about Zhonghe Life primarily focused on sales misguidance, automatic deductions, and disputes over policy terms [5]. Group 4: Product Performance and Refunds - The top three products with the highest refund scale in 2025 were from the "Family Evergreen" series of whole life insurance, with a total refund scale of approximately 422 million yuan [7]. - The refund rates for the "Family Evergreen" series products were notably high, indicating significant pressure on the company regarding policy cancellations [7]. Group 5: Related Transactions and Market Position - At the end of the previous year, Zhonghe Life disclosed two major related transactions, including a 350 million yuan agency fee cap with its major shareholder, Beijing Bank, and a 100 million yuan sales cooperation agreement with Nanjing Bank [8]. - Concerns have been raised about the company's reliance on shareholder channels, which may affect its business independence and market expansion [8].